News

Medically reviewed by Matthew Wosnitzer, MD Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of ...
A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...
Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...
The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...
The Midlands Today host and former TV-am presenter was diagnosed with prostate cancer in 2023 and has urged other men to get ...
A group of senior gym-goers who got their prostates checked at roughly the same time were shocked to find almost half of them ...
“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in ...
A prostate cancer spit test has brought a national screening programme for the disease a step closer, experts have said. The ...
Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...